Reagent blood analysis
Ended Awarded Last action
- Contract number
- 36C25022F0016
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,290
Award facts
- Contract value 58% obligated
-
- $49,251.84 Current, with exercised options
- $62,213.36 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$488 | |
| Exercise an Option | $12,962 | |
| Supplemental Agreement for work within scope | -$649 | |
| Exercise an Option | $12,962 | |
| Funding Only Action | -$809 | |
| Exercise an Option | $12,962 | |
| Exercise an Option | -$649 | |
| Modification | $12,962 | |
| Other Administrative Action | $0 |
About this award
Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, received a $62,213.36 firm fixed-price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 10 for reagent blood analysis services. This delivery order, awarded on October 1, 2021, with an ultimate completion date of September 30, 2026, represents a call against the company's existing GSA Schedule contract for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). The contract requires no small business set-aside designation, reflecting Werfen's status as a full-sized federal contractor. Performance of the work will take place in Bedford, Massachusetts, where the company maintains its manufacturing and distribution operations.
This delivery order aligns with Werfen USA LLC's established role as a key supplier of specialized laboratory diagnostic products and services to the VA system across multiple regional networks. The company maintains several significant blanket purchase agreements with various Veterans Integrated Service Networks, including similar arrangements for coagulation testing, blood gas instruments, and blood bank analyzers. The reagent blood analysis services procured under this delivery order support the VA's clinical laboratory operations, enabling point-of-care and centralized testing capabilities within the healthcare network to serve veteran patient populations.
Quick answers
Who was awarded contract 36C25022F0016?
36C25022F0016 was awarded to Werfen USA LLC by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C25022F0016 worth?
The government has obligated $36,290 on 36C25022F0016. Its current value, with exercised options, is $49,252. Its potential value, with all options, is $62,213.
Is contract 36C25022F0016 an order under another contract?
Yes. 36C25022F0016 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25022F0016 competed?
The extent of competition for 36C25022F0016 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award